Homology Medicines, Inc.

NASDAQ:FIXX

0.9347 (USD) • At close March 25, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 01.41800.3540.8020.8020.8020.8020.8020.8021.6772.18729.3050.980.5670.5670.5880.5630.4410.3920.270.980.9540.9260.8230000
Kosten van de omzet 01.2870.1360.5640.5870.6330.6350.786000000000000000000000
Brutowinst 00.131-0.136-0.210.2150.1690.1670.0160.8020.8021.6772.18729.3050.980.5670.5670.5880.5630.4410.3920.270.980.9540.9260.8230000
Brutowinstmarge 00.0920-0.5930.2680.2110.2080.02111111111111111110000
Onderzoek- en ontwikkelingskosten 9.8411.51317.51922.98219.98827.14925.85421.07524.27323.64623.98723.69721.75523.19520.41727.47129.3120.34225.69122.82720.53616.28113.39410.297.9989.5764.9474.0562.799
Algemene en administratieve kosten 5.0027.9016.8428.1888.3258.1477.818.03414.14710.7818.3519.0428.6617.5878.4238.7937.775.786.0385.5384.8575.0873.8434.5273.8282.6861.7181.9821.892
Verkoop- en marketingkosten 00000000000000000000000000000
Verkoop-, algemene en administratieve kosten 5.0027.9016.8428.1888.3258.1477.818.03414.14710.7818.3519.0428.6617.5878.4238.7937.775.786.0385.5384.8575.0873.8434.5273.8282.6861.7181.9821.892
Overige kosten 02.6876.640000000000000000000000000-0.876
Bedrijfskosten 14.8439.41431.00131.1728.31335.29633.66429.10938.4234.42732.33832.73930.41630.78228.8436.26437.0826.12231.72928.36525.39321.36717.23714.81711.82612.2636.6656.0394.692
Bedrijfsresultaat -14.843-9.414-31.001-30.816-27.511-34.494-32.862-28.307-37.618-33.625-30.661-30.552-1.111-29.802-28.273-35.697-36.492-25.559-31.288-27.973-25.123-20.387-16.283-13.891-11.002-12.263-6.665-6.039-4.692
Bedrijfsresultaat ratio 0-6.6390-87.051-34.303-43.01-40.975-35.296-46.905-41.926-18.283-13.97-0.038-30.41-49.864-62.958-62.061-45.398-70.948-71.36-93.048-20.803-17.065-14.993-13.3620000
Totaal overige inkomsten en kosten netto 16.0487.2591.4231.5111.4691.4551.2690.474131.2810.0420.0530.0520.0380.0110.0410.3571.1611.3921.6611.7031.2711.3861.4870.9960.4790.3570.1370.036-0.876
Inkomen voor belasting 1.205-2.155-29.578-29.305-26.042-33.039-31.593-27.83393.663-33.583-30.608-30.5-1.073-29.791-28.232-35.34-35.331-24.167-29.627-26.27-23.852-19.001-14.796-12.894-10.523-11.906-6.528-6.003-5.555
Inkomen voor belasting ratio 0-1.520-82.782-32.471-41.196-39.393-34.704116.787-41.874-18.252-13.946-0.037-30.399-49.792-62.328-60.087-42.925-67.181-67.015-88.341-19.389-15.507-13.917-12.780000
Belastingkosten 0.17613.9643.3765.7392.802-0.101-0.046-0.1050.9670000000000000000000-0.013
Nettowinst 1.029-16.119-32.954-35.044-28.844-32.938-31.547-27.72892.105-33.583-30.608-30.5-1.073-29.791-28.232-35.34-35.331-24.167-29.627-26.27-23.852-19.001-14.796-12.894-10.523-11.906-6.528-6.003-5.555
Nettowinstmarge 0-11.3670-98.994-35.965-41.07-39.335-34.574114.844-41.874-18.252-13.946-0.037-30.399-49.792-62.328-60.087-42.925-67.181-67.015-88.341-19.389-15.507-13.917-12.780000
WPA (Winst Per Aandeel) 1.03-50.01-102.53-109.14-89.96-103.14-99.34-87.51.61-106.01-97.2-97.2-3.83-118.57-112.36-140.71-140.85-98.95-121.46-109.77-114.84-93.3-71.45-62.97-42.09-115.2-63.16-58.08-53.75
Verwaterde WPA 0.44-50.01-102.53-109.14-89.96-103.14-98.85-86.971.59-105.85-96.48-97.17-3.83-118.57-112.36-140.71-140.85-96.34-121.46-109.77-114.84-91.49-71.45-62.97-42.09-115.2-63.16-58.08-53.75
EBITDA -14.843-9.414-31.001-30.599-27.286-34.198-32.541-27.979-168.519-31.552-28.562-28.4510.969-27.746-26.263-33.926-34.364-23.84-29.597-26.331-23.857-19.824-16.015-13.654-10.782-12.062-6.475-5.875-4.561
EBITDA ratio 0-6.6390-86.438-34.022-42.641-40.575-34.887-210.123-39.342-17.032-13.0090.033-28.312-46.319-59.834-58.442-42.345-67.113-67.171-88.359-20.229-16.785-14.737-13.0950000